Dropbox Inc vs IDEXX Laboratories, Inc. — how do they compare? Dropbox Inc trades at $34.36 (market cap $7.42B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 5.4× Dropbox Inc's market cap, and Dropbox Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Dropbox Inc for 97 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| DBX | IDXX | |
|---|---|---|
Market Cap | $7.42B | $40.43B |
Volume | 3,061,580 | 692,164 |
Sector | Technology | Health |
52-Week High | $37.74 | $766.68 |
52-Week Low | $22.06 | $504.70 |
Typical Hold Time | 97 Days | 46 Days |
Enterprise Value | $10.29B | $41.32B |
Signals from Pluang's Aura AI — not financial advice
Dropbox (DBX) trades at $34.14, up 3.2% today, with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable near $2.5B annually, while net income margin improved to 20.16% in 2025. However, negative shareholder equity and high debt levels pose fundamental concerns, and recent insider selling and a mixed analyst consensus indicate cautious sentiment.
The outlook is mixed: strong profitability and cash flow support valuation, but stagnant growth and insider disposals suggest limited upside. Key risks include competitive pressure in cloud storage and execution challenges. Investors should weigh solid fundamentals against sentiment headwinds.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Trailing returns across standard periods
Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →